Depression Syndrome Typing and Medication Pattern Analysis Through Unsupervised Clustering Combined With Latent Structure Dual Analysis

ZHU Huanxi, YU Cheng, LI Xuejun, WANG Ruixue, CHEN Yongjun, WANG Taiyi, WU Wenqing, YAO Lin

Abstract

Depression, a most common psychiatric disease, is defined in Traditional Chinese Medicine (TCM) as Yu Syndrome, i.e., depression disorder, or Baihe Disease, i.e., lily bulb disease, a category of emotional disorders treated with lily-based TCM preparations. In TCM, depression is managed through syndrome differentiation and treatment, which is characterized by high efficacy and safety. However, there is no unified standard for the classification of depression syndromes, which leads to a disconnection between the analysis of patients' medication patterns and their actual syndromes and hinders the study of medication patterns specific to particular syndromes. Therefore, this study is focused on investigating the medication patterns of different sub-types of depression patients based on an objective classification system of depression.

Methods 

We searched for and retrieved clinical literature on TCM formulas for depression from relevant databases, including China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP Database, Sinomed, Web of Science, and PubMed. Information on patient symptoms and medication was standardized. Then, the symptoms and the medication frequency of depression patients were statistically analyzed. We used the K-means clustering method combined with implicit structural analysis to objectively categorize depression patients into sub-types. In addition, the main symptoms and core TCM formulas of each sub-type of depression patients were identified. On the basis of objective classification system, we also statistically analyzed the characteristics of herbs used on depression patients, including the 4 basic properties, the 5 flavors, the attributes, the therapeutic efficacy, and the co-occurrence patterns, which may help reveal the medication patterns.

Results 

 A total of 3537 publications and 4434 prescriptions were included in the analysis. By using the K-means algorithm and latent structure analysis methods, patients with depression were categorized into 9 sub-types, with Cluster 6 accounting for the largest proportion. The most common symptoms among depression patients were insomnia and a depressed mood. Medication frequency analysis showed that Radix Bupleuri (Chai Hu), Radix Paeoniae Alba (Bai Shao), Poria (Fu Ling), Rhizoma Chuanxiong (Chuan Xiong), and Radix Curcumae (Yu Jin) were the most commonly used TCM herbs. For the depression sub-types of Clusters 1, 2, and 6, blood-activating and stasis-dissolving herbs were used most often. The depression sub-types of Clusters 3, 4, 5, 8, and 9 were mainly treated with qi-regulating herbs, while the depression sub-type of Cluster 7 was treated with qi-supplementing herbs. Depression patients were mostly treated with herbs that were cold or warm in nature and had sweet, bitter, and pungent flavors. Moreover, treatments for Cluster 1 and Cluster 6 mainly targeted the spleen meridian, while those for Cluster 2, Cluster 3, Cluster 4 and Cluster 5 mainly targeted the heart meridian. The treatments for the other sub-types mainly targeted the liver meridian. The core TCM formulas for the 9 depression sub-types included Zishui Qinggan Decoction, Danzhi Xiaoyao Powder, Huanglian Wendan Tang, Chaihu Guizhi Tang, Modified Xiaoyao Powder, Qinggan Jieyu Tang, Xiaoyao Powder, Xuefu Zhuyu Decoction, and Bazhen Decoction. The most commonly used Chinese herbal medicinal formulas were Gan Cao-Chai Hu, Bai Shao-Chai Hu, and Chen Pi-Chai Hu.

Conclusion 

 Based on machine learning, this study reveals the scientific aspects of TCM typing and syndrome-based treatment. It clarifies the rationale for targeting different symptoms in depression treatment and provides theoretical support for clinicians to make medication prescriptions. It also presents a new perspective for investigating TCM medication patterns.

 

Keywords: Depression, Syndrome typing, Medication patterns, K-means, Latent structure, Machine learning

 

Full Text:

PDF


References


MARWAHA S, PALMER E, SUPPES T, et al. Novel and emerging treatments for major depression. Lancet, 2023, 401(10371): 141-153. doi: 10.1016/S0140-6736(22)02080-3.

MONROE S M, HARKNESS K L. Major depression and its recurrences: life course matters. Annu Rev Clin Psychol, 2022, 18(1): 329-357. doi: 10. 1146/annurev-clinpsy-072220-021440.

CUI L L, LI S, WANG S M, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther, 2024, 9(1): 30. doi: 10.1038/s41392-024-01738-y.

ZHANG M X, LIU S. Recent advances in pharmacotherapy for depression. Acta Univ Sci Med Chongqing, 2024, 49(5): 631-637. doi: 10. 13406/j.cnki.cyxb.003506.

LI J J, DING Y Q. Huangqi Guizhi WUwu Decoction in treatment of depression of Qi Deficiency and Collateral Stasis syndrome. Shandong J Tradit Chin Med, 2019, 38(2): 154-157. doi: 10.16295/j.cnki.0257-358x. 2019.02.011.

QI M M, GUO R Q, MA J, et al. Syndrome Differentiation and treatment of Constraint syndrome based on the theory of resolving the Fire Constraint. J Nanjing Univ Tradit Chin Med, 2022, 38(9): 797-802. doi: 10.14148/j.issn.1672-0482.2022.0797.

WANG X J, TANG Y P, XU R Z, et al. Effect of dialectical behavior therapy and sertraline on adolescents with depressive disorder and non-suicidal self-injury behavior. Chin J Clin Psychol, 2024, 32(1): 234-237,197. doi: 10.16128/j.cnki.1005-3611.2024.01.043.

ZHANG M Y, XU E P, SHANG L Z, et al. Research progress on TCM syndrome differentiation and classification of depression. World Sci Technol Mod Tradit Chin Med, 2021, 23(11): 4251-4258. doi: 10.11842/wst.20210111001.

LI X J, WU X Y, LIU X, et al. Study on medication rules and mechanisms of patented traditional Chinese medicine compound formulas for depression treatment based on data mining and network pharmacology. Shanghai J Tradit Chin Med, 2024, 58(6):31-39. doi: 10.16305/j.1007-1334.2024.2309070.

LIU H F, CHEN J X, DY J, et al. Transforming complex problems into K-means solutions. IEEE Trans Pattern Anal Mach Intell, 2023, 1-20. doi: 10.1109/TPAMI.2023.3237667.

CHENG D D, HUANG J L, ZHANG S L, et al. K-means clustering with natural density peaks for discovering arbitrary-shaped clusters. IEEE Trans Neural Netw Learn Syst, 2024, 35(8): 11077-11090. doi: 10.1109/TNNLS.2023.3248064.

WANG S, LIU C, XING S J. Review on K-means clustering algorithm. J East China Jiaotong Univ, 2022, 39(5): 119-126. doi: 10.16749/j.cnki. jecjtu.20220914.001.

XU Y L, WU X Y, LI Y L, et al. Three methods of latent structure to determine the TCM syndrome based for the unlabeled data. World Sci Technol Mod Tradit Chin Med, 2019, 21(1): 101-108. doi: 10.11842/wst. 2019.01.018.

SONG J, WANG Z W. World Sci. Application progress of latent structure model based on different data types in traditional Chinese medicine research. World Sci Technol Mod Tradit Chin Med, 2022, 24(5): 2079-2084. doi: 10.11842/wst.20210808008.

KONG Q, HUANG X, ZHANG L Y, et al. Screening of Chinese medicine prescriptions for post-stroke aphasia based on complex network analysis and Delphi method. Global Tradit Chin Med, 2022, 15(3): 401-407. doi: 10.3969/j.issn.1674-1749.2022.03.007.

HU Y F, WANG G S, PEI Q H, et al. Clinical study on modified Zishui Qinggan decoction in the treatment of depression of liver depression and kidney deficiency type. Guid J Tradit Chin Med Pharm, 2024, 30(8): 87-91. doi: 10.13862/j.cn43-1446/r.2024.08.016.

GONG Q Y, HOU F L, LIU H, et al. Clinical study on modified Xiaoyao powder for post-stroke depression. New J Tradit Chin Med, 2020, 52(24): 38-40. doi: 10.13457/j.cnki.jncm.2020.24.012.

WAN F, LI X H, CHEN Y, et al. Effect of modified Chaihu Shugan San on CaMKⅡ/CREB signaling pathway in rats with myocardial ischemia and depression. Chin J Exp Tradit Med Formulae, 2025, 31(9):1-11. doi: 10.13422/j.cnki.syfjx.20241902.

LIU J M, WANG Y L, HUANG H, et al. Exploring Mechanism of Hei Xiaoyaosan Regulating PI3K/Akt Pathway to Improve Learning and Memory Ability of Insomnia Rats with Liver Depression Syndrome Based on Transcriptomics. Chin J Exp Tradit Med Formulae, 2024: 1-16. doi: 10.13422/j.cnki.syfjx.20250764.

WU M D, LIU L M, SU P, et al. Research progress on anti-depression effect of Danzhi Xiaoyao Powder from perspective of neuroinflammation. Chin Tradit Herb Drugs, 2024, 55(7): 2442-2451. doi: 10.7501/j.issn.0253-2670.2024.07.030.

YAO Z C, LIU T Y, MEI Y, et al. Prospective Randomized Controlled Study of Huanglian Wendan Decoction in Treatment of post-stroke Depression. Liaoning J Tradit Chin Med, 2024, 51(6): 115-119. doi: 10. 13192/j.issn.1000-1719.2024.06.031.

QI X, LU J Q, WEN Z H, et al. Mechanism exploring of Wendan Decoction in treatment of coronary heart disease combined with depression based on network pharmacology and molecular docking. Drug Eval Res, 2022, 45(8): 1540-1548. doi: 10.7501/j.issn.1674-6376.2022.08. 011.

LI D, LIU G Y, PAN L, et al. Advances in clinical application and pharmacological mechanisms of Chaihu Guizhi Decoction for neuropsychiatric disorders. Chin Tradit Pat Med, 2024, 46(8): 2677-2684. doi: 10.3969/j.issn.1001-1528.2024.08.030.

JI X L, ZHOU Y, LI Z H, et al. Progress on historical evolution, clinical application, and pharmacological effects of Dachaihu Decoction and predictive analysis of its quality markers. China J Chin Mater Med, 2024, 49(8): 2064-2075. doi: 10.19540/j.cnki.cjcmm.20231209.201.

ZHOU Y, TIAN N J, ZHAO W X, et al. Effect of Qingxin Jieyu Decoction on Depression patients with liver depression and spleen deficiency type. Liaoning J Tradit Chin Med, 2024, 51(9): 126-129. doi: 10.13192/j.issn. 1000-1719.2024.09.035.

WU J J, BIAN Q L, DING F M, et al. Research progress on antidepressant effect of Xiaoyao Powder. Chin Arch Tradit Chin Med, 2024, 42(7): 116-119. doi: 10.13193/j.issn.1673-7717.2024.07.026.

WANG W K, ZHANG W, SUN Y, et al. Effects of Danggui Buxue Decoction and its main active ingredient ferulic acid on CUMS model GK rats. Tradit Chin Drug Res Clin Pharmacol, 2020, 31(6): 649-654. doi: 10. 19378/j.issn.1003-9783.2020.06.005.

ZHANG Z Q, ZHOU H Y, ZHAO Q, et al. Effects of Modified shaoyao gancao decoction on intestinal transit function, intestinal flora and metabolite content in slow transit constipation rat. China Pharm, 2025, 36(2): 154-159. doi: 10.6039/j.issn.1001-0408.2025.02.04.

LI J X, ZHANG L, LI W, et al. Meta-analysis of clinical efficacy of Xuefu Zhuyu Decoction for post-stroke depression. Shanghai J Tradit Chin Med, 2023, 57(3): 15-20. doi: 10.16305/j.1007-1334.2023.2207059.

LU Y J, ZHANG S, SHI W, et al. Effects of Chaihu-Shugan San on behavior and hippocampal neurogenesis in depression model mice. Chin J Behav Med Brain Sci, 2022, 31(3): 198-204. doi: 10.3760/cma.j. cn371468-20210918-00538.

ZHENG D H, YU M, JIN Z, et al. Identification of the antidepressant fraction and its major chemical constituents of Radix Paeoniae Alba. Acta Pharm Sin, 2023, 58(5): 1307-1316. doi: 10.16438/j.0513-4870.2022-1165.

YANG X X, LIANG J J, DONG R. Comparative study on the chemical constituents and anti-depression of Bupleurum Radix-Paeoniae Radix Alba single flavor, drug-pair formula granules and traditional decoction. Nat Prod Res Dev, 2024, 36(7): 1182-1190.

PAN X, CHEN K Z, HAN S J, et al. Total triterpenes of Wolfiporia cocos (Schwein. ) ryvarden & gilb exerts antidepressant-like effects in a chronic unpredictable mild stress rat model and regulates the levels of neurotransmitters, HPA axis and NLRP3 pathway. Front Pharmacol, 2022, 13: 793525. doi: 10.3389/fphar.2022.793525.

YU B, RUAN M, XU L, et al. Chuanxiong injection improves neurological function of post-stroke depression rats through cAMP-CREB-BDNF pathway. Chin Pharmacol Bull, 2022, 38(8): 1246-1251. doi: 10.12360/CPB202202035.

HU C Y, CAO X X, WANG X L, et al. Research progress of chemical constituents, preparations and pharmacological effect of essential Oil of Chuanxiong (Chuanxiong Rhizoma). J Liaoning Univ Tradit Chin Med, 2024, 26(3): 124-130. doi: 10.13194/j.issn.1673-842x.2024.03.028.

MA J F, WANG D, LI T, et al. Pharmacological mechanism of Curcumae Radix in treatment of post-stroke depression: a review. Chin J Exp Tradit Med Formulae, 2022, 28(7): 276-282. doi: 10.13422/j.cnki.syfjx.20220740.

ZHANG H Y, ZHANG Y P, ZHANG Y J, et al. Ameliorative effect and mechanism of curcumin on diabetes model rats with depression. China Pharm, 2024, 35(8): 942-947. doi: 10.6039/j.issn.1001-0408.2024.08.08.

WANG S Y, LI J C, JI S Z, et al. Treatment of depression based on the theory of "liver disease affecting to the spleen". J Beijing Univ Tradit Chin Med, 2025, 48(2): 216-222. doi: 10.3969/j.issn.1006-2157.2025.02.010.


Refbacks

  • There are currently no refbacks.